干混悬剂

  • 网络Suspension;dry suspension
干混悬剂干混悬剂
  1. 为控制药品质量,保证临床用药的安全有效,本论文对该品种从原料药到干混悬剂进行了质量研究和评价;

    In order to have quality of the drug under control to ensure its safety and efficiency , comparative study and evaluation on Cefpodoxime Proxetil drug substance as well as its dry suspensions were carried out in this thesis .

  2. 目的观察口服克拉霉素干混悬剂的相对生物利用度。

    Objective : To observe the relative bioavailability of clarithromycin dry suspension ( RDS ) .

  3. 头孢泊肟酯口服干混悬剂中苯甲酸钠的HPLC测定

    Determination of Sodium Benzoate in Cefpodoxime Proxetil for Oral Suspension by HPLC

  4. 罗红霉素颗粒和干混悬剂溶出度HPLC测定法的建立

    Development of the dissolution methods for roxithromycin granules and roxithromycin for suspension by HPLC

  5. HPLC法测定复方布洛芬干混悬剂中布洛芬及苯巴比妥钠的含量

    Determination of Fenbufen Tablets by HPLC Determination of Ibuprofen and Sodium Phenobarbital in Compound Ibuprofen for Suspension by HPLC

  6. 建立了HPLC法测定雷尼酸锶干混悬剂的含量和有关物质。

    HPLC method was established for the determination of the content of strontium ranelate for suspension and its related substances .

  7. 目的:研究受试制剂头孢克肟干混悬剂(A)、胶囊剂(B)和参比制剂(C,头孢克肟胶囊,世福素)的人体生物等效性。

    OBJECTIVE : To study the bioequivalence of suspension formulation of cefixime ( A ), capsule formulation of ce-fixime ( B ) and reference preparation ( C : Cefixime Capsules or Cefspan ) in human body .

  8. 方法:用微生物法测定10名男性健康志愿者分别口服罗红霉素干混悬剂和片剂各150mg后的血药浓度,以观察罗红霉素干混悬剂的相对生物利用度。

    METHODS : The study was conducted in 10 male volunteers .

  9. 同皮肤细胞匀浆代谢相似,酮洛芬异丙酯被代谢成原药酮洛芬。HPLC法测定复方布洛芬干混悬剂中布洛芬及苯巴比妥钠的含量

    Ketoprofen isopropyl ester was hydrolyzed into ketoprofen when penetrated through the cultured skin , which resembled in the skin cell homogenates metabolism . Determination of Ibuprofen and Sodium Phenobarbital in Compound Ibuprofen for Suspension by HPLC

  10. 方法:狗口服NTZ干混悬剂,剂量分别为50mg/kg·bw、100mg/kg·bw和200mg/kg·bw,用HPLC法测定血药浓度,并计算药物动力学参数。

    Methods : Following administration of a single dose of 50 , 100 and 200mg / kg dry suspension of Nitazoxanide to dogs , blood drug concentrations were determined by HPLC .

  11. 研究了健康狗口服NTZ(nitazoxanide)干混悬剂的主要活性代谢产物替唑尼特的药物动力学过程及药动学特征。

    The pharmacokinetics of the main activity metabolin of dry suspension of Nitazoxanide was studied in dogs .

  12. 选择自然感染复孔绦虫的犬6只,按200mg/Kgbw的剂量一次口服此干混悬剂(按NTZ计100mg/Kgbw)。

    Six dogs , infected naturally with Dipylidium caninum were given 200mg / kg bw NTZ dry suspension ( equal to 100mg / kg bw NTZ ) respectively .

  13. 以沉降体积比、再分散性、pH值为考察指标,采用正交设计试验对NTZ干混悬剂处方进行筛选,并考察优选处方的流体性能、粒径分布及稳定性。

    In order to select an optimized recipe of NTZ for dry suspension , an orthogonal design experiment was carried out by determination of the ratio setting volume , redispersibility and pH value of the suspensions .

  14. 结果不同制药公司及同一公司生产的不同批号的片剂、干混悬剂的溶出度基本上能达到《中华人民共和国药典》规定标准(即45min溶出度分别≥80%)。

    Results The dissolution of azithromycin tablets and azithromycin suspension from the different pharmaceutical companies basically meet the standard of Ch. P ( dissolution of 45 min have achieved ≥ 80 % ) .

  15. 伊维菌素干混悬剂对绵羊寄生虫的驱杀效果与安全性研究

    Effect and safety of ivermectin dry suspension agent against sheep parasites

  16. 对乙酰氨基酚缓释干混悬剂中对氨基酚限量的控制

    Quantitative limitation of p-aminophenol for paracetamol sustained release suspension by HPLC

  17. 正交设计筛选莪术油干混悬剂处方

    Screening of the Zedoary turmeric oil suspension formulation by orthogonal design

  18. 阿奇霉素干混悬剂的人体药动学及生物等效性研究

    Pharmacokinetics and Relative Bioavailability of Azithromycin Dried Suspension in Human Body

  19. 克拉维酸钾阿莫西林干混悬剂稳定性影响因素的考察

    Factors influencing the stability of the suspension containing potassium clavulanate and amoxicillin

  20. 萘丁美酮干混悬剂的制备及其初步稳定性研究

    Preparation of Nabumetone suspension and preliminary study on its stability

  21. 伊维菌素干混悬剂驱除猪蛔虫效果与安全性试验

    Effective and safe experiment of Ivermectin dry suspension on expelling Ascaris Suam

  22. 阿奇霉素干混悬剂在治疗社区获得性儿科感染性疾病中的顺应性考察

    Evaluated the Tolerability of Azithromycin Desiccated Suspension in Treating Community-acquired Paediatric Infections

  23. 伊维菌素干混悬剂对羊狂蝇蛆的驱杀效果试验

    Effect of Ivermectin dry suspension agent on deworming oestrus ovis Larva in sheep

  24. 头孢泊肟酯干混悬剂在健康志愿者中的生物等效性

    The bioequivalence of cefpodoxime oral suspension in healthy volunteers

  25. 掩味头孢丙烯干混悬剂的制备及质量控制

    Preparation and Quality Control of Taste-masked Cefprozil Dry Suspension

  26. 关于干混悬剂质量标准的商榷

    Discussion about the Quality Standards of Drugs for Suspension

  27. 目的研究琥乙红霉素干混悬剂的人体药代动力学和生物等效性。

    Objective To study the human pharmacokinetics and bioequivalence of erythromycin ethylsuccinate suspension .

  28. 苯酰甲硝唑干混悬剂的人体生物等效性研究

    Studies of the Bioequivalence of Benzoyl Metronidazole Dry Suspension

  29. 头孢氨苄口服干混悬剂稳定性的研究

    Studies on the Shelflife of Cephalexin Oral Suspension

  30. 浊度法测定吉他霉素片与乙酰吉他霉素干混悬剂中主药的效价

    Titer Determination of Main Component in Kitasamycin Tablets and Acetylkitasamycin Dry Suspension by Turbidimetry